General Information

Size and Evolution
The ryanodine receptor (RyR) is a selective Ca 2+ release channel that is localized to the endoplasmic reticulum (ER) in both excitable and non-excitable cells. The RyR owes its name to the plant alkaloid and high affinity ligand ryanodine. The functional RyR exists as a tetramer composed of a single unit of approximately 565kDa. To date, it is the largest known ion channel. In mammals, there are three RyR isoforms that share approximately 70% homology and several biophysical properties (26) . RyR1 is the dominant Ca 2+ release channel present on sarcoplasmic reticulum (SR) in skeletal muscles (104, 127) , RyR2 is predominant in cardiac muscle (73) , and in brain there is more general expression of all three isoforms (29, 36, 67, 73, 126) . Based on phylogenetic analysis, it is likely that all three RyR isoforms evolved from a single ancestor. In addition, there is evidence to suggest that the RyR as well as another intracellular Ca 2+ channel the inositol 1,4,5-trisphosphate receptor (IP3R) evolved from a common ancestral gene (107) . Sequence analysis reveals a high degree of similarity in the channel pore region (107) , supporting the common ancestor theory. This structural homology is also present between the pore-forming region of RyRs and other ion channels, which include voltage gated ion channels, cyclic nucleotide gated channels, and the transient receptor potential channels (TRP) (41) . Phylogenetic studies also reveal that certain RyR domains are highly conserved from worms to humans. For instance, there is 35-40% homology at the amino acid level between C. elegans and vertebrates, and the functional domains including the leucine/isoleucine zipper, the pore region, and the transmembrane domains are highly conserved in all three RyR isoforms. Mutations in these domains alter channel functions such as caffeineinduced Ca 2+ release, ryanodine binding, single channel conductance, and cation selectivity (31, 122). 
The RyR genes
Three-dimensional structure and ligand binding
Three-dimensional (3D) structural information is essential to an understanding of the functional properties of RyRs. While there are no published full length crystal structures of the RyR, there are several crystal structures of the N-terminal domain, and they reveal structural similarities with the IP3R (62, 92) . Cryo-electron microscopy (EM) generated 3D reconstructions of RyR reveal a highly conserved structure, having the overall shape of a mushroom and consisting of two major components: a large, square prism-shaped cytoplasmic assembly composed of at least 10 distinct domains, and a differentiated small transmembrane assembly (Figure 1 ). Sequence analysis (104, 106) and biochemical studies (20, 37) demonstrate that the N-terminus (~4000-4500 amino acid residues) contains the large cytoplasmic assembly, while the C-terminus (~500-1000 amino acid residues) comprises the transmembrane regions (Figure 2 ). The precise number of transmembrane segments per single monomer unit is controversial; four-, six-, and tensegment models have been proposed (20 Figure 3 ) (66).
Post-translational modifications
In addition to regulation by ligand binding, RyR opening is controlled by post-translational modifications that include covalent phosphorylation, nitrosylation, and redox potential (oxidation/reduction of cysteine sulfhydryl moieties). Three major phosphorylation sites exist on the RyR and physiologically regulate RyR conductance. They include serine (S)2814, S2030, and S2808. S2814 and S2030 are phosphorylated by CaMKII and PKA, respectively. It is not yet resolved which of the kinases--CaMKII, PKA, or PKG--phosphorylates S2808 on RyR2.
Increasing evidence supports the redox modulation of RyR channels (44, 84, 112) . A small number of hyper-reactive sulfhydryls on RyR are susceptible to oxidation (40), Snitrosylation (5, 22) , and S-glutathionylation (3) by a number of endogenous redox-active agents. Typically, exposure of RyR to these agents increases its sensitivity towards activators or decreases its sensitivity towards inhibitors (3, 75) . 
The RyR pore
The RyR pore is the region which provides a pathway for ions to cross the dielectric barrier of the ER membrane and shares much of its architecture with K + channels. The putative membrane-spanning regions, which make up the RyR pore, have been identified within the last 1000 residues of the C-terminus (20, 104, 127) . The ion handling properties of the RyR pore have also been examined in detailed (111) . Although the RyR effectively excludes anions, it does not discriminate between cations as well. RyR channels are permeable to a wide range of divalent and monovalent inorganic cations and some organic monovalent cations. The rate of cation translocation through the RyR pore is higher than those of other ion channels (111) . Because the RyR behaves as a single ion channel, the most likely explanation is that the RyR pore contains a short, wide, selectivity filter. 
RyR-associated pathologies
Over 300 RyR mutations have been associated with disorders (54), including the RyR myopathies malignant hyperthermia (69, 72) , central core disease (63) , multiminicore disease (25), atypical periodic paralyses (125) , catecholaminergic polymorphic ventricular tachycardia, and arrhythmogenic right ventricular dysplasia type 2 (64, 87, 120) . The RyR has also been indirectly linked to acquired pathologies such as heart failure (95) and over-exercise muscle fatigue (4).
The following references provide a more comprehensive review of RyR structure and function (26, 39, 54, 90, 118, 126) . 
Pancreatic Information
RyR expression in the pancreas
Several groups have examined RyR isoforms in both acinar cells and islets. Muallem and colleagues failed to see expression of RyRs in rat pancreatic acini by immunofluorescence (IF) (57) . Later, however, Nathanson and colleagues demonstrated expression of RyR2 by PCR and western blotting (59) . By IF, they saw a non-apical pattern of labeling. A similar distribution of the RyR signal was observed by several labs including those of Yule (using BODIPY-ryanodine) (100) and Pandol (27) . The latter found that all three isoforms were expressed. Our lab has further confirmed the presence of RyR in rat (Figure 4) (6, 47, 50) . These studies were recently complemented with the interesting finding that a novel RyR2 splice variant exists in mouse pancreatic islets (107) . The protein product is present in both mouse and human islets and remains fully functional. Lastly, Wehrens and colleagues confirmed the original findings that RyR2 is the predominant isoform, with the addition that RyR3 is also expressed at low levels (6).
Figure 4. In mouse pancreatic acinar cells the ryanodine receptor (RYR) is localized to the basolateral region, and RYR1 is expressed. (A) Left:
RYR is distributed in the basolateral region (Ba) of the acinar cell but excluded from the apical region (Ap Notably, neither dantrolene nor micromolar ryanodine (the latter from a previous study (74)) affected enzyme secretion. The findings implicate the RyR as a potential therapeutic for pancreatitis without the side-effect of perturbing pancreatic function (46, 78) . Ethanol, a major etiology of pancreatitis, given at concentrations that are achievable during intoxication (100 mM) accelerated the apical to basal Ca 2+ wave generated by carbachol (79) .
The RyR in pancreas pathology
Ethanol also enhanced intra-acinar protease activation and acinar cell injury. These changes were dependent on the RyR (Figure 6 ). Another study confirmed that RyR inhibition (using ruthenium red) modulated pathological Ca 2+ release and protease activation due to ethanol exposure in permeabilized acinar cells (33) . Although the mechanism by which ethanol sensitizes RyRs is still unclear, a potential target is post-translational modifications by PKA phosphorylation (94) . Ethanol is readily converted by the pancreas to its non-oxidative metabolites in the presence of fatty acids to fatty acid ethyl esters (55) . Whereas the oxidative metabolites induce mild Ca 2+ signals, several of the non-oxidative metabolites including palmitoleic acid ethyl ester (POAEE) and ethyl palmitate both induce strong Ca 2+ signals and convert oscillatory signals with physiological stimuli to that of a pathologic peak-plateau pattern (16, 17, 19) . The Ca 2+ signals with POAEE were partially dependent on the RyR (34). Bile acid exposure of acinar cells may constitute an important mechanism of biliary pancreatitis (82, 83) . The bile acid taurolithocholic acid 3-sulfate (TLCS) induces robust peak-plateau Ca 2+ signals (32, 108) and acinar cell injury that are dependent upon the RyR (45) . Further, in vivo pancreatitis due to infusion of bile acids (TLCS or taurocholic acid; TC) can be prevented and, importantly, treated with the RyR inhibitor dantrolene (45) . These data do not negate the potential involvement of IP3Rs that are concentrated in the apical region but also sparsely distributed along the ER in the basal region of the acinar cell. Overall, however, the findings provide potential for the use of RyR modulators as an adjunctive therapy for pancreatitis. Recent studies have also examined the importance of the RyR in pancreatic islets. It has previously been established that the RyR serves an important function in regulating Ca 2+ handling, insulin secretion, and glucose tolerance in pancreatic islets (6, 50) . 
Tools for Study
Antibodies
A list of RyR antibodies and their applications are provided in Table 2 .
Expression vectors
RyR1 and RyR2 have been overexpressed in HEK293 cells by Chen and colleagues (49) . These constructs have proven useful for examining the role of various mutations on RyR Ca 2+ release.
Animal models
The RyR1 (102) and RyR2 (103) knockout mice do not survive beyond neonatal life, while RyR3 deficient mice live to adulthood (7). Currently, there are no floxed conditional knockouts. There is, however, a knockout of CD38, the enzyme that synthesizes the putative RyR activator cADPR (77, 117) . There are also knockins of the phosphomimetic and phosphoresistant mutations at S2808 and S2814 on RyR2 (95, 96) . A certain strain of pig has a higher incidence of RyR mutations that predispose them to malignant hyperthermia (99) . A knockin mouse model of malignant hyperthermia has also been established (24) . . 
Ligand binding
Activators and inhibitors
A list of RyR activators and inhibitors are in Table  1 .
Pull-down
Pull-down of RyR is achieved with high affinity using a FKBP12 or FKBP12.6 GST fusion protein (51, 61) . 
81)
The only drug targeting RyRs to be used clinically (113, 128 
